Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharmaceuticals Share Price (FARN)

Share Price Information for Faron Pharmaceuticals (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 98.50
Bid: 97.00
Ask: 100.00
Change: 0.50 (0.51%)
Spread: 3.00 (3.093%)
Open: 98.00
High: 98.50
Low: 98.00
Prev. Close: 98.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Faron Pharmaceuticals Oy Ord Npv (di)

Faron Pharmaceuticals is listed in the FTSE AIM All-Share index.

Faron Pharmaceuticals Oy Ord Npv (di) is listed on the London Stock Exchange trading with ticker code FARN.L. It has a market capitalisation of £85.38m, with approximately 86.68m shares in issue. Over the last year, Faron Pharmaceuticals share price has been traded in a range of 271.00, hitting a high of 360.00, and a low of 89.00.

Faron Pharmaceuticals is a clinical-stage biopharmaceutical company headquartered in Turku, Finland. Founded in 2007, it focuses on developing novel treatments for severe medical conditions with significant unmet needs. The company's pipeline includes innovative therapies for cancer, acute respiratory distress syndrome (ARDS), and other life-threatening diseases. Faron Pharmaceuticals is committed to advancing its proprietary technologies and conducting rigorous clinical trials to bring effective solutions to patients. With a strong emphasis on scientific research and collaboration, Faron aims to improve patient outcomes and contribute to the advancement of global healthcare.

Faron Pharmaceuticals Share Price
Price 98.50
Bid 97.00
Ask 100.00
Change 0.50 (0.51%)
Volume 107,836
Open 98.00
High 98.50
Low 98.00
Prev. Close 98.00
Currency GBX
Issue Country GB
Shares in Issue 86.68m
Market Capitalisation £85.38m
Market Size 750
52 Week High 360.00
52 Week High Date 11-Dec-2023
52 Week Low 89.00
52 Week Low Date 20-Jun-2024
# Trades 23
Vol. Sold 17,809
Sold Value £17.38k
Vol. Bought 25,564
Bought Value £25.43k
PE Ratio -2.841742
Earnings -34.66184
Dividend 0.00
Yield 0.00%
Great for
Spread Betting and CFDs
Capital at risk.
Go to site
Great for
0% commission
Other fees apply.
Capital at risk.
Go to site
Great for
Larger Investment Pots
Capital at risk.
Go to site
Great for
Low Fees
Capital at risk.
Go to site

Recent Share Trades for Faron Pharmaceuticals (FARN)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
20-Jun-2408:07:3690.0043,005Unknown*97.00100.0038.70kO Ordinary
Delayed publication
Historical
21-Jun-2417:07:3198.5050,000Unknown*97.00100.0049.25kO Ordinary
Was reported as OTC
21-Jun-2414:28:1996.1557,000Unknown*97.00100.006,731O Ordinary
Delayed publication
21-Jun-2414:34:4998.90600Buy*97.00100.00593.40O Ordinary
21-Jun-2414:13:0397.005,500Sell*97.00100.005,335O Ordinary
21-Jun-2414:10:3898.21421,500Sell*97.00100.001,473O Ordinary
21-Jun-2414:07:3997.32723,620Sell*97.00100.003,523O Ordinary
21-Jun-2413:05:4598.12112,463Unknown*97.00100.0012.23kO Ordinary
Delayed publication
20-Jun-2416:30:1385.0040,000Unknown*97.00100.0034.00kO Ordinary
Delayed publication
Historical
20-Jun-2416:30:1385.00-40,000Unknown*97.00100.00-34.00kO Ordinary
Deletion
Delayed publication
Historical

Directors Deals for Faron Pharmaceuticals (FARN)

Announced Traded Action Notifier Price Currency Amount Holding
04-Apr-2403-Apr-24PlacingTuomo Pätsi held the position of Non-Executive Director at the time of this trade.Tuomo Pätsi1.50EUR13,333250,980
04-Apr-2403-Apr-24PlacingMarkku Jalkanen held the position of CEO at the time of this trade.Markku Jalkanen1.50EUR33,3332,208,599
27-Oct-2312-Oct-23SellJohn Poulos held the position of Independent Non-Executive Director at the time of this trade.John Poulos382.59GBX5,00010,000
27-Oct-2303-Oct-23SellJohn Poulos held the position of Independent Non-Executive Director at the time of this trade.John Poulos372.09GBX5,00010,000
31-Aug-2328-Aug-23Exercise of OptionJohn Poulos held the position of Independent Non-Executive Director at the time of this trade.John Poulos1.09EUR20,00020,000
Faron Pharmaceuticals

We offer a promising immunotherapy candidate with a new target to fight cancer.

Faron Pharmaceuticals Home Page

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.